Distribution of Neurochemical Deficits in Alzheimer’s Disease
- 1 January 1990
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Tacrine, a Drug with Therapeutic Potential for Dementia: Post-Mortem Biochemical EvidenceCanadian Journal of Neurological Sciences, 1989
- Authors' response to commentariesNeurobiology of Aging, 1989
- Galanin-Like Immunoreactivity Is Unchanged in Alzheimer's Disease and Parkinson's Disease Dementia Cerebral CortexJournal of Neurochemistry, 1988
- Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEGPsychopharmacology, 1987
- The dementia of Alzheimer's disease: an update.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's diseaseAnnals of Neurology, 1986
- BIOCHEMICAL STUDIES OF NERVE CELLS AND ENERGY METABOLISM IN ALZHEIMER'S DISEASEBritish Medical Bulletin, 1986
- Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's diseaseNature, 1986
- Neurochemical Studies of Early-Onset Alzheimer's DiseaseNew England Journal of Medicine, 1985
- Role of Ca2+ in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomesBiochemical Journal, 1985